Call Options

26 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $6.13 Million - $7.45 Million
-37,400 Reduced 27.95%
96,400 $19 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $20.8 Million - $24.2 Million
-134,100 Reduced 50.06%
133,800 $22.9 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $13.8 Million - $15.8 Million
86,600 Added 47.77%
267,900 $48.8 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $11.7 Million - $13.2 Million
-85,200 Reduced 31.97%
181,300 $28.1 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $11.3 Million - $13 Million
84,300 Added 46.27%
266,500 $39.7 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $2.41 Million - $3 Million
-18,200 Reduced 9.08%
182,200 $24.5 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $4.53 Million - $5.21 Million
31,300 Added 18.51%
200,400 $31.9 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $788,367 - $945,459
5,700 Added 3.49%
169,100 $27.3 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $2.55 Million - $2.92 Million
-19,000 Reduced 10.42%
163,400 $21.9 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $17.5 Million - $22.3 Million
127,200 Added 230.43%
182,400 $27.9 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $2.82 Million - $3.5 Million
21,400 Added 63.31%
55,200 $8.95 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $180,880 - $205,326
-1,700 Reduced 4.79%
33,800 $3.65 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $3.3 Million - $3.68 Million
31,400 Added 765.85%
35,500 $4 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $2.71 Million - $2.98 Million
-26,500 Reduced 86.6%
4,100 $444,000
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $1.44 Million - $1.95 Million
17,900 Added 140.94%
30,600 $3.28 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $2.96 Million - $3.47 Million
-34,400 Reduced 73.04%
12,700 $1.11 Million
Q2 2020

Sep 10, 2020

SELL
$73.37 - $98.18 $4.45 Million - $5.96 Million
-60,700 Reduced 56.31%
47,100 $4.62 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $8.22 Million - $12.5 Million
-127,500 Reduced 54.19%
107,800 $8.21 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $10.1 Million - $12.6 Million
-140,000 Reduced 37.3%
235,300 $20.8 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $16.5 Million - $21.1 Million
251,800 Added 203.89%
375,300 $27.3 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $17.3 Million - $20.4 Million
-224,700 Reduced 64.53%
123,500 $9.95 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $295,830 - $364,838
3,800 Added 1.1%
348,200 $32.1 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $6.15 Million - $6.84 Million
-69,200 Reduced 16.73%
344,400 $32.6 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $19.3 Million - $22.9 Million
-215,100 Reduced 34.21%
413,600 $38.3 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $55.9 Million - $74.8 Million
607,200 Added 2824.19%
628,700 $59.5 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $1.93 Million - $2.11 Million
21,500
21,500 $2.08 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.